Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterusWarner K. Huh, Michael J. Birrer, Michael W. Sill et al.|Gynecologic Oncology|2010Cited by 41
Gestational trophoblastic neoplasia: Computed tomographic appearanceMarco A. Amendola, James Hoffman, Beatriz E. Amendola et al.|Computerized Medical Imaging and Graphics|1983Cited by 3